TP53INP1 and lung carcinoma: However, Han et al demonstrated that miR‐106a accelerated cell migration and EMT process in lung adenocarcinoma through targeting TP53INP1, suggesting that miR‐106a exacerbated bone metastasis in lung cancer.21